Magenta Medical Ltd., founded in 2012 and based in Kadima, Israel, specializes in developing innovative device solutions for the treatment of acute and chronic heart failure. The company's primary focus is on a temporary venous catheter-based therapy designed specifically for patients experiencing acute decompensated heart failure. By addressing critical needs within this medical field, Magenta Medical aims to improve patient outcomes through its advanced therapeutic technologies.
Everside Health is a direct primary care provider offering convenient on-site, near-site, and virtual care for its members. Everside’s data-driven, patient-centric healthcare delivery model aligns incentives to benefit the patient, the physician, and the benefit provider, all while reducing the total cost of care.
Celcuity Inc. is a clinical-stage biotechnology company based in Minneapolis, Minnesota, focused on advancing cancer care through innovative diagnostic and therapeutic solutions. The company's CELsignia diagnostic platform analyzes living tumor cells from patients to identify the specific abnormal cellular processes driving their cancer, enabling personalized treatment options. Celcuity is developing the CELsignia HSF test to diagnose new sub-types of HER2-negative breast cancer, as well as the CELsignia MP test to identify multiple cancer sub-types across various types, including breast, lung, colon, ovarian, kidney, and bladder cancers. In addition to its diagnostic efforts, Celcuity is advancing a lead therapeutic candidate, gedatolisib, a potent pan-PI3K and mTOR inhibitor, which is currently being evaluated in a Phase 3 clinical trial for patients with HR+/HER2- advanced breast cancer. Founded in 2011, Celcuity aims to transform the treatment landscape for patients with cancer by providing targeted therapies tailored to their unique disease profiles.
Developer of an online teleconsultation platform designed to guide women during and after menopause. The company's platform has online access to specialized doctors, science-backed pieces of information and treatments with conversations and information about effective care for changing hormones, enabling women to live longer and healthier lives.
InCarey is a comprehensive medical service platform based in Shanghai, China, founded in 2011. The company specializes in the management of patients with chronic and vertical diseases, integrating medical, pharmaceutical, and insurance resources to deliver a one-stop solution for long-term healthcare needs. Its cloud-based platform offers professional disease management services, facilitating one-on-one interactions between doctors and patients. Additionally, InCarey's e-commerce capabilities enable users to obtain medications for major diseases efficiently. The platform is designed to address the complexities of chronic disease management, providing innovative payment solutions and a streamlined approach to healthcare services.
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.
Recludix pharma is a developing platform to discover potent and selective inhibitors of challenging protein targets. The platform approach integrates custom generated DNA-encoded libraries, massively parallel determination of structure-activity relationships, and a proprietary screening tool to ensure selectivity.
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The platform enables users to select and enroll in various affordable health coverage options, including dental, vision, and prescription insurance plans. Stride Health simplifies the process of finding suitable health insurance by providing personalized recommendations and tax deduction support, thereby helping customers maximize their take-home pay. The company, originally known as Covered, Inc., rebranded to Stride Health in March 2013 and has since been based in San Francisco, California. Through its services, Stride Health aims to make healthcare accessible and manageable for its users.
Sisu is the fastest and most comprehensive diagnostic platform for structured data. Based on years of research at Stanford University and proven at scale at Microsoft, Facebook and Google, Sisu’s diagnostic analytics platform combines machine learning and powerful statistical analysis to help anyone get answers to their toughest business questions. To learn more about Sisu, visit www.sisu.ai.
Vori Health is an all-inclusive medical and health provider practicing a holistic, integrated approach starting with musculoskeletal care. It offers full-service physical medicine and rehabilitation care, physical therapy, prescriptions, imaging and lab ordering, health coaching, nutritional guidance, community support, and premium instructional content. The team consists of carefully selected, board-certified physicians and licensed healthcare providers, and provides health services that are accessible at the click of a button from the comfort, convenience, and privacy of a patient's home. The company was founded in 2020 and is headquartered in San Francisco, California.
Spiras Health is a healthcare company focused on enhancing patient outcomes by providing home-based care for individuals with complex chronic illnesses. The company extends specialist care into patients' homes through a multidisciplinary team of clinicians. By utilizing telehealth services, two-way digital communications, and remote patient monitoring, Spiras Health aims to improve patients' quality of life while simultaneously reducing costs associated with avoidable hospitalizations. This approach not only increases access to necessary medical services but also addresses the challenges faced by patients managing chronic conditions.
AllyAlign Health, Inc. is a care management company dedicated to supporting patients with chronic and complex medical conditions. Founded in 2013 and based in Glen Allen, Virginia, the company utilizes an active care management platform that facilitates real-time, collaborative care across various boundaries. This platform connects patients with care teams, providers, and home and community-based services, ensuring access to vital health information, care plans, and benefits needed for informed decision-making. Users can easily view, share, create, and update information according to their roles, with mobile and web-based options available for convenient access. The company maintains a central, HIPAA-compliant database that integrates information from diverse sources, such as electronic health records, lab tests, and pharmacy data, while employing semantic data modeling to present meaningful clinical insights.
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.
Vori Health is an all-inclusive medical and health provider practicing a holistic, integrated approach starting with musculoskeletal care. It offers full-service physical medicine and rehabilitation care, physical therapy, prescriptions, imaging and lab ordering, health coaching, nutritional guidance, community support, and premium instructional content. The team consists of carefully selected, board-certified physicians and licensed healthcare providers, and provides health services that are accessible at the click of a button from the comfort, convenience, and privacy of a patient's home. The company was founded in 2020 and is headquartered in San Francisco, California.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Code Biotherapeutics
Seed Round in 2021
Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. Code Bio leverages its novel multivalent synthetic DNA delivery platform, 3DNA, which has been engineered to overcome many of the challenges inherent with viral-based gene therapies such as immunogenicity, size and delivery limitations, re-dosability, and manufacturing complexity. The Company is advancing an internal pipeline focused on select rare disease programs as well as establishing partnerships to take forward programs in both rare and prevalent diseases.
Strive Health, LLC, founded in 2018 and headquartered in Denver, Colorado, focuses on providing comprehensive solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enabled clinical model that enhances patient outcomes and experiences throughout the healthcare journey. Strive Health collaborates with innovative payors and providers to transform kidney care by utilizing predictive analytics and comparative data to identify at-risk patients. Additionally, the company emphasizes early intervention through redesigned primary care practices to treat kidney disease before it necessitates dialysis. By offering education, training, and care management, Strive Health aims to reduce inpatient utilization and promote the adoption of home dialysis, ultimately improving the overall quality of care for patients with chronic kidney disease.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
Cardionomic, Inc. develops a catheter-based medical device aimed at treating acute decompensated heart failure (ADHF) through neuromodulation. This innovative technology electrically stimulates cardiac nerves to enhance the heart's pumping action, which is crucial for improving cardiac output, renal blood flow, urine production, and pharmacological tolerance. The device is inserted into the right pulmonary artery via the internal jugular vein and selectively stimulates autonomic nerves that control ventricular contractility without altering heart rate. By targeting the root cause of ADHF, Cardionomic's therapy not only increases contractility but also leads to reductions in plasma norepinephrine and B-type natriuretic peptide, both of which are biomarkers of chronic heart failure. Established in 2007 and headquartered in New Brighton, Minnesota, Cardionomic aims to enhance patient outcomes in acute heart failure management.
ChromaCode, Inc. is a molecular diagnostics company based in Carlsbad, California, that specializes in developing innovative testing solutions for infectious diseases, cancer, and non-invasive prenatal testing (NIPT) using proprietary technology derived from Caltech. The company enhances the performance of quantitative polymerase chain reaction (qPCR) instruments, achieving a five-fold increase in multiplexing capabilities while maintaining cost-effectiveness. ChromaCode employs advanced bioinformatics techniques and patented mathematical methods to improve signal processing, enabling laboratories to conduct comprehensive testing of multiple targets in a single sample. Additionally, the company offers products such as the HDPCR Tick-Borne Pathogen Panel, which detects various tick-borne pathogens through a multiplex polymerase chain reaction test. Founded in 2012, ChromaCode draws expertise from professionals with backgrounds in leading organizations such as Illumina and Google[x].
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.
Sisu is the fastest and most comprehensive diagnostic platform for structured data. Based on years of research at Stanford University and proven at scale at Microsoft, Facebook and Google, Sisu’s diagnostic analytics platform combines machine learning and powerful statistical analysis to help anyone get answers to their toughest business questions. To learn more about Sisu, visit www.sisu.ai.
Magenta Medical Ltd., founded in 2012 and based in Kadima, Israel, specializes in developing innovative device solutions for the treatment of acute and chronic heart failure. The company's primary focus is on a temporary venous catheter-based therapy designed specifically for patients experiencing acute decompensated heart failure. By addressing critical needs within this medical field, Magenta Medical aims to improve patient outcomes through its advanced therapeutic technologies.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
THE WELL is a modern membership-based wellness club designed for busy urban professionals. They bring together Western doctors and Eastern healers to collaborate, developing online content and personalized products and experiences that empower their community to take greater agency for their health.
The company recognizes both the benefits of Western medicine and the wisdom of Eastern healing and have built a science-backed ecosystem for wellness. The Well's integrative medicine doctors, health coaches, and skilled practitioners work together under one roof to build customized plans uniquely suited to each member and their goals.
Strive Health, LLC, founded in 2018 and headquartered in Denver, Colorado, focuses on providing comprehensive solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enabled clinical model that enhances patient outcomes and experiences throughout the healthcare journey. Strive Health collaborates with innovative payors and providers to transform kidney care by utilizing predictive analytics and comparative data to identify at-risk patients. Additionally, the company emphasizes early intervention through redesigned primary care practices to treat kidney disease before it necessitates dialysis. By offering education, training, and care management, Strive Health aims to reduce inpatient utilization and promote the adoption of home dialysis, ultimately improving the overall quality of care for patients with chronic kidney disease.
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule, tumor-agnostic therapies. The company's lead product candidate, BDTX-189, is designed to inhibit specific mutations in ErbB kinases, including the epidermal growth factor receptor. Additionally, Black Diamond is advancing a pipeline of allosteric-EGFR mutation inhibitors and other early-stage programs targeting allosteric mutations in kinases associated with cancer and rare genetic diseases. The company employs a technology platform known as Mutation-Allostery-Pharmacology, which aims to address undrugged mutations in patients with genetically defined cancers. Founded in 2014 and based in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its rebranding in 2018.
Lungpacer Medical Inc. is a medical device company based in Vancouver, Canada, with an additional office in Exton, Pennsylvania. Founded in 2009, the company specializes in developing therapeutic solutions for critically ill patients who require mechanical ventilation. Its primary product, the Lungpacer DPT System, is a diaphragm pacing system designed to preserve and restore the strength of the diaphragm muscle. This innovative system utilizes the body's nervous system to stimulate the diaphragm, enabling repetitive exercises that help rebuild muscle strength and endurance. By addressing diaphragm muscle disuse atrophy, Lungpacer aims to improve the overall respiratory health of patients, facilitating better outcomes in critical care settings.
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.
GOQii Inc. provides digital health and wellness solutions through its advanced wearable technology and a comprehensive application. The company's offerings include activity trackers that monitor sleep, physical activity, and calorie expenditure, along with features like caller ID and alerts. Users can connect with a variety of health and fitness coaches, including nutritionists and personal trainers, who offer personalized advice based on individual health data through private chats or video calls. The application also facilitates medical consultations and diagnostic test bookings, while allowing users to store health records securely in the cloud. Founded in 2013, GOQii is headquartered in Menlo Park, California, with additional offices in Mumbai and Shenzhen, and is committed to promoting healthier lifestyles through sustained engagement and a blend of technology and human support.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
Everside Health is a direct primary care provider offering convenient on-site, near-site, and virtual care for its members. Everside’s data-driven, patient-centric healthcare delivery model aligns incentives to benefit the patient, the physician, and the benefit provider, all while reducing the total cost of care.
MORE Health, Inc. is a healthcare technology company that offers a cloud-based platform designed to enhance physician collaboration. This platform connects patients' attending doctors with specialists to collaboratively develop accurate diagnoses and optimal treatment plans. Key features include a clinical database containing medical histories, hospital records, and lab results, as well as medical imaging tools and HIPAA-compliant video conferencing for discussions. The company also provides a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and secure medical record services for traveling employees. Originally established as a concierge service for individuals, MORE Health now extends its offerings to U.S. companies as an employer-sponsored health benefit, facilitating access to top physicians for serious medical issues through Co-Diagnosis or Independent Second Opinion services. Founded in 2013 and based in Foster City, California, MORE Health collaborates with renowned medical institutions, including The George Washington Medical Faculty Associates, Boston Children's Hospital, and UCLA Health, with the aim of becoming a virtual global hospital for serious illnesses.
Everside Health is a direct primary care provider offering convenient on-site, near-site, and virtual care for its members. Everside’s data-driven, patient-centric healthcare delivery model aligns incentives to benefit the patient, the physician, and the benefit provider, all while reducing the total cost of care.
Aetion, Inc. develops a science and analytics platform to assess real-world evidence (RWE) from a range of sources. The company offers Aetion Evidence Platform, a platform that generates RWE needed by healthcare decision makers to engage in value-based care. Its solution allows payers, providers, medical device makers, biopharma customers, and academic institutions to analyze data from various clinical and financial interactions in healthcare, including claims, electronic health records, registries, and clinical trials. The company’s platform is also used in database analytics and comparative effectiveness courses taken by epidemiologists, outcomes researchers, health economists, and biostatisticians. It serves customers worldwide. Aetion, Inc. has a strategic collaboration with McKesson. The company was founded in 2012 and is based in New York, New York.
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
MORE Health, Inc. is a healthcare technology company that offers a cloud-based platform designed to enhance physician collaboration. This platform connects patients' attending doctors with specialists to collaboratively develop accurate diagnoses and optimal treatment plans. Key features include a clinical database containing medical histories, hospital records, and lab results, as well as medical imaging tools and HIPAA-compliant video conferencing for discussions. The company also provides a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and secure medical record services for traveling employees. Originally established as a concierge service for individuals, MORE Health now extends its offerings to U.S. companies as an employer-sponsored health benefit, facilitating access to top physicians for serious medical issues through Co-Diagnosis or Independent Second Opinion services. Founded in 2013 and based in Foster City, California, MORE Health collaborates with renowned medical institutions, including The George Washington Medical Faculty Associates, Boston Children's Hospital, and UCLA Health, with the aim of becoming a virtual global hospital for serious illnesses.
Radiology Partners Holdings, LLC, founded in 2012 and headquartered in Manhattan Beach, California, operates within the healthcare sector as a radiology practice center. The company is dedicated to transforming the way radiologists deliver services, catering to hospitals, referring physicians, and patients. By focusing on enhancing the efficiency and effectiveness of radiology services, Radiology Partners aims to improve patient care and support healthcare facilities in meeting their diagnostic needs.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.
Metavention, Inc., established in 2012 and headquartered in Dover, Delaware, specializes in the development of trans-catheter devices aimed at modulating sympathetic nervous system activity. These innovative devices address the issues of over-active sympathetic nerves that contribute to elevated glucose levels and abnormal liver function. By employing standard interventional vascular techniques, Metavention provides healthcare professionals with a novel tool for diagnosing and treating patients with Type 2 diabetes. The company focuses on enhancing treatment options for this condition, ultimately improving patient outcomes.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The platform enables users to select and enroll in various affordable health coverage options, including dental, vision, and prescription insurance plans. Stride Health simplifies the process of finding suitable health insurance by providing personalized recommendations and tax deduction support, thereby helping customers maximize their take-home pay. The company, originally known as Covered, Inc., rebranded to Stride Health in March 2013 and has since been based in San Francisco, California. Through its services, Stride Health aims to make healthcare accessible and manageable for its users.
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in continuous glucose monitoring (CGM) systems for individuals with diabetes, primarily in Europe. Founded in 1996, the company develops advanced implantable CGM products, including Eversense and Eversense XL, which monitor glucose levels for up to 90 and 180 days, respectively. Using innovative fluorescence sensing technology, these systems are designed to provide high accuracy and stability throughout their extended sensor life. The company aims to empower people with diabetes to manage their condition more effectively and confidently through its CGM solutions, which also include a smart transmitter and a mobile app. A significant portion of Senseonics' revenue is generated from markets outside the United States.
Radiology Partners Holdings, LLC, founded in 2012 and headquartered in Manhattan Beach, California, operates within the healthcare sector as a radiology practice center. The company is dedicated to transforming the way radiologists deliver services, catering to hospitals, referring physicians, and patients. By focusing on enhancing the efficiency and effectiveness of radiology services, Radiology Partners aims to improve patient care and support healthcare facilities in meeting their diagnostic needs.
EPIX Therapeutics develops and manufactures products for use in electrophysiology based on microwave radiometry technology. Its products provide real-time feedback of energy delivered by catheters during cardiac ablation procedures. The company has a strategic relationship with Hansen Medical Inc. Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced it has changed its name to EPIX Therapeutics, Inc.
ChromaCode, Inc. is a molecular diagnostics company based in Carlsbad, California, that specializes in developing innovative testing solutions for infectious diseases, cancer, and non-invasive prenatal testing (NIPT) using proprietary technology derived from Caltech. The company enhances the performance of quantitative polymerase chain reaction (qPCR) instruments, achieving a five-fold increase in multiplexing capabilities while maintaining cost-effectiveness. ChromaCode employs advanced bioinformatics techniques and patented mathematical methods to improve signal processing, enabling laboratories to conduct comprehensive testing of multiple targets in a single sample. Additionally, the company offers products such as the HDPCR Tick-Borne Pathogen Panel, which detects various tick-borne pathogens through a multiplex polymerase chain reaction test. Founded in 2012, ChromaCode draws expertise from professionals with backgrounds in leading organizations such as Illumina and Google[x].
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.
Ardelyx, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for cardiorenal diseases. Headquartered in Fremont, California, Ardelyx's lead product candidate, tenapanor, has successfully completed Phase 3 clinical trials for treating irritable bowel syndrome with constipation and is also in Phase 3 trials for managing hyperphosphatemia in end-stage renal disease patients undergoing dialysis. The company is advancing RDX013, a small molecule potassium secretagogue, aimed at treating hyperkalemia. Ardelyx is also developing RDX5791, an oral NHE3 sodium transport inhibitor targeting constipation-predominant irritable bowel syndrome and excess dietary sodium absorption, currently in Phase 2 trials. Additionally, RDX002 and RDX009, which inhibit phosphate absorption and target type 2 diabetes, respectively, are in preclinical development. Ardelyx emphasizes non-systemic oral therapeutics that minimize side effects while effectively addressing metabolic disorders. Since its founding in 2007, the company has secured significant funding to support its research and development efforts.
Docent Health's mission is to help health systems build and retain lasting patient relationships. We are combining best practices from other industries to help health systems deliver the vision of customer-centric care by combining cutting edge consumer technology, retail based strategic marketing, and hospitality inspired service excellence with deep provider experience to increase customer lifetime value and grow market share.
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.
NeueHealth is a health care service platform that focuses on improving patient experiences and outcomes through a combination of technology and local healthcare resources. It operates 61 affiliated primary care clinics that deliver both virtual and in-person clinical care to nearly 75,000 unique patients. NeueHealth is part of Bright Health Group, which also offers Medicare and commercial health plan products to approximately 623,000 consumers across 14 states. The company aims to reduce healthcare costs while enhancing access and quality of care by aligning the interests of consumers, providers, and payers. Founded in 2015 and based in Minneapolis, Minnesota, NeueHealth leverages intelligent technology to connect users with healthcare services and providers effectively.
LinkDoc Technology Limited develops medical data solutions and oncology big data platforms. It offers clinical structured data for oncology hospitals and hospitals to assist hospitals in solving scientific and clinical problems. The company was founded in 2014 and is headquartered in Beijing, China.
DOTS Technology Corp, founded in 2013 and located in Natick, Massachusetts, operates a diagnostic platform designed to assist consumers with food allergies. The company is focused on developing a food allergen detection system that allows users to test food on the spot, providing immediate information to enhance decision-making and improve the overall quality of life for individuals affected by food allergies. By advancing point-of-care detection technology, DOTS aims to address the needs of millions of consumers and has applications in both consumer and industrial sectors.
Docent Health's mission is to help health systems build and retain lasting patient relationships. We are combining best practices from other industries to help health systems deliver the vision of customer-centric care by combining cutting edge consumer technology, retail based strategic marketing, and hospitality inspired service excellence with deep provider experience to increase customer lifetime value and grow market share.
GOQii Inc. provides digital health and wellness solutions through its advanced wearable technology and a comprehensive application. The company's offerings include activity trackers that monitor sleep, physical activity, and calorie expenditure, along with features like caller ID and alerts. Users can connect with a variety of health and fitness coaches, including nutritionists and personal trainers, who offer personalized advice based on individual health data through private chats or video calls. The application also facilitates medical consultations and diagnostic test bookings, while allowing users to store health records securely in the cloud. Founded in 2013, GOQii is headquartered in Menlo Park, California, with additional offices in Mumbai and Shenzhen, and is committed to promoting healthier lifestyles through sustained engagement and a blend of technology and human support.
Personal Genome Diagnostics develops a patient-specific analysis of the cancer genome by using advanced tools and technologies. They were the first to sequence and analyze whole human cancer exomes and subsequently identified many alterations responsible for the development of cancer. They have described the principles underlying the genetic basis of human cancer and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Through PGDx, our founders bring their proprietary methods and expertise to research teams worldwide. The services help oncologists and translational scientists sequence and analyze cancer genomes and identify mutations to characterize aspects of the disease. Their expertise in genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. They specialize in high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive “liquid biopsy” approaches in cancer. Personal Genome Diagnostics was founded in 2010 and is based in Baltimore, Maryland, United States.
Cardionomic, Inc. develops a catheter-based medical device aimed at treating acute decompensated heart failure (ADHF) through neuromodulation. This innovative technology electrically stimulates cardiac nerves to enhance the heart's pumping action, which is crucial for improving cardiac output, renal blood flow, urine production, and pharmacological tolerance. The device is inserted into the right pulmonary artery via the internal jugular vein and selectively stimulates autonomic nerves that control ventricular contractility without altering heart rate. By targeting the root cause of ADHF, Cardionomic's therapy not only increases contractility but also leads to reductions in plasma norepinephrine and B-type natriuretic peptide, both of which are biomarkers of chronic heart failure. Established in 2007 and headquartered in New Brighton, Minnesota, Cardionomic aims to enhance patient outcomes in acute heart failure management.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
23andMe, Inc. is a consumer genetics company that provides DNA analysis services through home-based saliva collection kits, enabling users to explore their ancestry, inherited traits, and health insights. Founded in 2006 and headquartered in Sunnyvale, California, the company offers various services, including Health + Ancestry and Ancestry + Traits, which provide insights into a person's genetic background and over 30 trait reports. 23andMe aims to help individuals understand the implications of their genetic information while also catering to researchers by offering categorized and searchable data. The company was co-founded by Linda Avey and Anne Wojcicki and has positioned itself as a significant player in the growing biotechnology and healthcare sectors.
CrowdMed, Inc. is a healthcare technology company based in San Francisco, California, established in 2012. It utilizes a prediction market platform to address complex medical issues by tapping into the collective intelligence of a network of medical detectives, which includes licensed physicians, medical students, and other healthcare professionals. This innovative approach allows CrowdMed to provide patients with potential diagnoses and solutions for undiagnosed or chronic symptoms that have eluded traditional medical practices. By combining the insights of numerous contributors, CrowdMed aims to deliver accurate and timely medical suggestions, thereby streamlining the healthcare process. The company seeks to become a trusted resource for millions of patients facing challenging medical conditions.
Proteostasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cystic fibrosis and other diseases linked to protein homeostasis. The company’s primary product candidates include PTI-801, a CFTR corrector; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. Proteostasis employs theratyping to tailor treatment strategies based on individual responses to CFTR modulators, regardless of specific mutations. The company collaborates with the Cystic Fibrosis Foundation and Genentech to advance its research and development efforts. Founded in 2006 and based in Boston, Massachusetts, Proteostasis was previously known as Proteoguard, Inc. and rebranded in 2007. In December 2020, it was acquired by Yumanity Therapeutics in a reverse merger transaction.
Median Technologies is a company that develops and markets software products and platforms for medical image analysis, focusing on oncology clinical trials and cancer screening. Founded in 2002 and based in Valbonne, France, it offers solutions such as iBiopsy, an AI-powered platform that aids in biomarker identification and patient profiling through CT scan similarity searches, and iSee, which facilitates image analysis and management in clinical trials. The company aims to standardize and automate the interpretation of medical images to enhance the diagnosis of cancer and evaluate treatment responses. Median Technologies serves both drug development and patient care markets, partnering with contract research organizations and Canon to deliver integrated imaging services and innovate new imaging technologies.
Ardelyx, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for cardiorenal diseases. Headquartered in Fremont, California, Ardelyx's lead product candidate, tenapanor, has successfully completed Phase 3 clinical trials for treating irritable bowel syndrome with constipation and is also in Phase 3 trials for managing hyperphosphatemia in end-stage renal disease patients undergoing dialysis. The company is advancing RDX013, a small molecule potassium secretagogue, aimed at treating hyperkalemia. Ardelyx is also developing RDX5791, an oral NHE3 sodium transport inhibitor targeting constipation-predominant irritable bowel syndrome and excess dietary sodium absorption, currently in Phase 2 trials. Additionally, RDX002 and RDX009, which inhibit phosphate absorption and target type 2 diabetes, respectively, are in preclinical development. Ardelyx emphasizes non-systemic oral therapeutics that minimize side effects while effectively addressing metabolic disorders. Since its founding in 2007, the company has secured significant funding to support its research and development efforts.
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The platform enables users to select and enroll in various affordable health coverage options, including dental, vision, and prescription insurance plans. Stride Health simplifies the process of finding suitable health insurance by providing personalized recommendations and tax deduction support, thereby helping customers maximize their take-home pay. The company, originally known as Covered, Inc., rebranded to Stride Health in March 2013 and has since been based in San Francisco, California. Through its services, Stride Health aims to make healthcare accessible and manageable for its users.
ClarVista Medical, Inc. is a California-based company that specializes in developing innovative products for ophthalmic conditions. Founded in 2012 as a spin-off from a medical device incubator, the company focuses on its flagship product, the HARMONI modular intraocular lens system. This system is designed to optimize vision during cataract surgery by allowing for the initial positioning of the lens and the easy exchange of the lens optic, thus enabling healthcare practitioners to tailor procedures to meet individual patient needs. ClarVista Medical has established a robust portfolio of intellectual property and has conducted clinical studies to validate its technology. The company has secured significant funding to advance the development of the HARMONI system and to pursue necessary regulatory approvals.
MORE Health, Inc. is a healthcare technology company that offers a cloud-based platform designed to enhance physician collaboration. This platform connects patients' attending doctors with specialists to collaboratively develop accurate diagnoses and optimal treatment plans. Key features include a clinical database containing medical histories, hospital records, and lab results, as well as medical imaging tools and HIPAA-compliant video conferencing for discussions. The company also provides a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and secure medical record services for traveling employees. Originally established as a concierge service for individuals, MORE Health now extends its offerings to U.S. companies as an employer-sponsored health benefit, facilitating access to top physicians for serious medical issues through Co-Diagnosis or Independent Second Opinion services. Founded in 2013 and based in Foster City, California, MORE Health collaborates with renowned medical institutions, including The George Washington Medical Faculty Associates, Boston Children's Hospital, and UCLA Health, with the aim of becoming a virtual global hospital for serious illnesses.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Champions Oncology, Inc. specializes in developing technology solutions and products aimed at personalizing the treatment of cancer. The company employs its Tumorgraft Technology Platform, which involves implanting human tumors in immune-deficient mice, to provide Personalized Oncology Solutions (POS). This platform enables physicians to tailor treatment options based on specific tumor data obtained from drug panels. Additionally, Champions Oncology offers Translational Oncology Solutions to assist pharmaceutical and biotechnology companies in their drug development processes. The company's product offerings include TumorGraft implants and drug panels that evaluate the response of a patient's tumor to various oncology drugs or combinations. Champions Oncology markets its products through online channels, referrals, and a dedicated sales team. Founded by leading experts in cancer research and treatment, the company is headquartered in Hackensack, New Jersey, and was incorporated in 1985.
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The platform enables users to select and enroll in various affordable health coverage options, including dental, vision, and prescription insurance plans. Stride Health simplifies the process of finding suitable health insurance by providing personalized recommendations and tax deduction support, thereby helping customers maximize their take-home pay. The company, originally known as Covered, Inc., rebranded to Stride Health in March 2013 and has since been based in San Francisco, California. Through its services, Stride Health aims to make healthcare accessible and manageable for its users.
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.
LinkDoc Technology Limited develops medical data solutions and oncology big data platforms. It offers clinical structured data for oncology hospitals and hospitals to assist hospitals in solving scientific and clinical problems. The company was founded in 2014 and is headquartered in Beijing, China.
Private Equity Round in 2015
U.S. Renal Care, Inc. is a healthcare service provider that operates a comprehensive network of outpatient, home, and specialty dialysis centers across the United States, serving over 25,000 patients in 335 facilities. Founded in 2000 and based in Plano, Texas, the company specializes in providing both in-center and at-home hemodialysis and peritoneal dialysis for individuals suffering from chronic kidney failure and end-stage renal disease. U.S. Renal Care also manages dialysis programs in acute settings in partnership with local hospitals. The organization emphasizes collaboration with nephrologists through joint venture partnerships to enhance patient care, while also supporting families, caregivers, and healthcare professionals involved in the treatment of kidney disease. The company has a presence in 32 states, including the Territory of Guam.
Interleukin Genetics, Inc. is a company that specializes in personalized health through genetic testing. It develops and sells genetic tests aimed at helping individuals improve their health and wellness. The company focuses on two main areas: providing genetic test products directly to consumers and through sales partners, and conducting research and development to create genetic tests in collaboration with partners for medical and dental applications. By offering personalized insights related to chronic diseases and health conditions, Interleukin Genetics aims to empower individuals with the information needed to make informed decisions about their health, including specific dietary and exercise recommendations. This approach aligns with their mission of enhancing preventive health measures and improving overall health outcomes.
Median Technologies is a company that develops and markets software products and platforms for medical image analysis, focusing on oncology clinical trials and cancer screening. Founded in 2002 and based in Valbonne, France, it offers solutions such as iBiopsy, an AI-powered platform that aids in biomarker identification and patient profiling through CT scan similarity searches, and iSee, which facilitates image analysis and management in clinical trials. The company aims to standardize and automate the interpretation of medical images to enhance the diagnosis of cancer and evaluate treatment responses. Median Technologies serves both drug development and patient care markets, partnering with contract research organizations and Canon to deliver integrated imaging services and innovate new imaging technologies.
BetterDoctor, Inc. is a company based in San Francisco, California, that specializes in developing web and mobile applications to assist users in finding healthcare providers. Founded in 2011, BetterDoctor allows users to specify the type of doctor they need and select their insurance plan to view a list of verified healthcare professionals. The company's platform provides accurate provider data to health plans, health systems, and various organizations through its API, facilitating the search for doctors and improving healthcare access. BetterDoctor's services have reached millions of users, powering numerous health plans and companies by enhancing the transparency and reliability of doctor data. As of June 2018, BetterDoctor operates as a subsidiary of Quest Analytics, L.L.C.
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in continuous glucose monitoring (CGM) systems for individuals with diabetes, primarily in Europe. Founded in 1996, the company develops advanced implantable CGM products, including Eversense and Eversense XL, which monitor glucose levels for up to 90 and 180 days, respectively. Using innovative fluorescence sensing technology, these systems are designed to provide high accuracy and stability throughout their extended sensor life. The company aims to empower people with diabetes to manage their condition more effectively and confidently through its CGM solutions, which also include a smart transmitter and a mobile app. A significant portion of Senseonics' revenue is generated from markets outside the United States.
EPIX Therapeutics develops and manufactures products for use in electrophysiology based on microwave radiometry technology. Its products provide real-time feedback of energy delivered by catheters during cardiac ablation procedures. The company has a strategic relationship with Hansen Medical Inc. Advanced Cardiac Therapeutics, Inc. (ACT), a medical device company that designs and manufactures a catheter-based system for the treatment of patients with atrial fibrillation (AFIB), today announced it has changed its name to EPIX Therapeutics, Inc.
Welltok is a data-driven enterprise SaaS company based in Denver, Colorado, that specializes in consumer activation within the healthcare sector. Founded in 2009, Welltok provides a health optimization platform that connects health plans, employers, providers, and public entities with consumers by offering personalized guidance and incentives for health improvement. The platform utilizes a large consumer database and machine learning to enhance audience engagement in healthy activities. By facilitating targeted actions, Welltok enables organizations to foster meaningful connections with individuals, encouraging them to take purposeful steps towards optimizing their health and wellbeing.
NeoTract, Inc. develops surgical devices for urological and gynecological disorders.
Fire1, based in Dublin, Ireland, is dedicated to developing innovative therapeutic devices aimed at enhancing the lives of heart failure patients. The company has created a remote monitoring system that allows healthcare providers to access real-time patient data and insights. This technology facilitates the early detection of complications associated with heart failure, enabling proactive interventions that can lead to improved patient outcomes. Through its focus on remote monitoring, Fire1 seeks to address critical challenges in heart failure management and contribute to better healthcare solutions.
Gu Sheng Tang (GST) is a China-based healthcare services provider that operates a chain of private clinics specializing in traditional Chinese medicine.
Collective Health offers a cloud-based platform that transforms how self-insured employers manage health benefits. This integrated system allows companies to administer various health plans through a single portal, providing employees with clear guidance, live concierge support, and digital tools to navigate their healthcare options. By focusing on a smarter alternative to traditional health insurance, Collective Health aims to enhance the value of healthcare investments while improving employee care. The company has experienced significant growth in the employer-sponsored insurance market, currently covering 70,000 employee and dependent lives across 15 employers, including notable clients such as Activision Blizzard, Crossfit, eBay, Palantir, and Red Bull.
Topera Medical (Topera, Inc.), a venture-backed medical device company, has developed a novel 3D analysis and mapping system to assist electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. The Topera System, which consists of the RhythmView Workstation and the FIRMap diagnostic catheter, is designed to improve patient outcomes by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of and treatment planning for a variety of arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia, and ventricular tachycardia.
Omada Health, Inc. is a digital healthcare company that creates online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health helps employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the needs of participants, including services for diabetes prevention and management, hypertension, behavioral health, and musculoskeletal issues. By integrating professional health coaching, connected devices, real-time data, and personalized feedback, Omada Health strives to empower individuals to engage with their health and achieve sustainable lifestyle changes. It is recognized as the largest provider of the National Diabetes Prevention Program by the CDC.
CrowdMed, Inc. is a healthcare technology company based in San Francisco, California, established in 2012. It utilizes a prediction market platform to address complex medical issues by tapping into the collective intelligence of a network of medical detectives, which includes licensed physicians, medical students, and other healthcare professionals. This innovative approach allows CrowdMed to provide patients with potential diagnoses and solutions for undiagnosed or chronic symptoms that have eluded traditional medical practices. By combining the insights of numerous contributors, CrowdMed aims to deliver accurate and timely medical suggestions, thereby streamlining the healthcare process. The company seeks to become a trusted resource for millions of patients facing challenging medical conditions.
MediSys Edutech is focused on enhancing healthcare education by developing innovative teaching and learning aids tailored for medical, dental, nursing, and paramedical students, particularly in remote areas of India. The company has pioneered healthcare e-learning by creating multimedia-enhanced curricular content and e-lectures that supplement traditional teaching methods in medical colleges. One of its key offerings, SmarTeach® UGMed, provides a digital version of MBBS theory classes aligned with the Medical Council of India syllabus. This platform allows educators to project e-content in classrooms, thereby enriching the learning experience, while also granting students access to virtual lectures through e-libraries, personal laptops, and smart devices. MediSys aims to make tele-teaching and interactive medical learning accessible and effective through various channels, including Wi-Fi campuses and mobile technology.
23andMe, Inc. is a consumer genetics company that provides DNA analysis services through home-based saliva collection kits, enabling users to explore their ancestry, inherited traits, and health insights. Founded in 2006 and headquartered in Sunnyvale, California, the company offers various services, including Health + Ancestry and Ancestry + Traits, which provide insights into a person's genetic background and over 30 trait reports. 23andMe aims to help individuals understand the implications of their genetic information while also catering to researchers by offering categorized and searchable data. The company was co-founded by Linda Avey and Anne Wojcicki and has positioned itself as a significant player in the growing biotechnology and healthcare sectors.
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic diseases that require long-term treatment. The company is known for its innovative Medici Drug Delivery System, which utilizes subcutaneous delivery methods to provide steady dosing of therapeutic agents, particularly for conditions such as type 2 diabetes and obesity. Its flagship product, ITCA 650, is currently in a phase 3 clinical program aimed at improving treatment outcomes for diabetes patients through a unique delivery mechanism. In addition to diabetes, Intarcia is engaged in research and development for therapies targeting autoimmune disorders and other chronic conditions. Founded in 1995 and headquartered in Boston, Massachusetts, Intarcia also has a manufacturing facility in Hayward, California, and a research center in Durham, North Carolina.
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic diseases that require long-term treatment. The company is known for its innovative Medici Drug Delivery System, which utilizes subcutaneous delivery methods to provide steady dosing of therapeutic agents, particularly for conditions such as type 2 diabetes and obesity. Its flagship product, ITCA 650, is currently in a phase 3 clinical program aimed at improving treatment outcomes for diabetes patients through a unique delivery mechanism. In addition to diabetes, Intarcia is engaged in research and development for therapies targeting autoimmune disorders and other chronic conditions. Founded in 1995 and headquartered in Boston, Massachusetts, Intarcia also has a manufacturing facility in Hayward, California, and a research center in Durham, North Carolina.